Calithera is focused on discovering and developing small molecule drugs that slow tumor growth through controlling key metabolic pathways in the tumor and immune cells.Tumor metabolism and tumor immunology are promising new interrelated fields for cancer drug discovery. Recent clinical successes have demonstrated the potential to slow abnormal cell growth and create fundamentally new therapies for cancer patients. Our investigational onco-metabolism medicines take advantage of the different metabolic requirements of tumor cells and cancer-fighting immune cells.Calithera’s discovery and development efforts are focused on diseases for which new treatments are urgently needed, for patients suffering from renal cell carcinoma, triple negative breast cancer and other solid tumors.
|Bank Name||Calithera Biosciences, Inc.|
|CEO||Dr. Susan M. Molineaux|